Boston Scientific (NYSE: BSX) received FDA approval for the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE